Ortin Global (BOM:539287) Total Liabilities: ₹34.10 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:539287 Ortin Global Ltd BOM:539287
43 GF Score
Price ₹15.00
GF Value ₹2.50
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Ortin Global Total Liabilities?

Ortin Global BOM:539287 43 Total Liabilities is ₹34.10 Mil as of Mar. 2026. GuruFocus rates BOM:539287 with a GF Score™ of 43/100 and a GF Value™ of ₹2.50 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Ortin Global's Total Liabilities for the quarter that ended in Mar. 2026 was ₹34.10 Mil.

Ortin Global's quarterly Total Liabilities declined from Sep. 2025 (₹25.26 Mil) to Dec. 2025 (₹0.00 Mil) but then increased from Dec. 2025 (₹0.00 Mil) to Mar. 2026 (₹34.10 Mil).

Ortin Global's annual Total Liabilities declined from Mar. 2024 (₹38.40 Mil) to Mar. 2025 (₹18.03 Mil) but then increased from Mar. 2025 (₹18.03 Mil) to Mar. 2026 (₹34.10 Mil).

Ortin Global Total Liabilities Historical Data

* Premium members only.

The historical data trend for Ortin Global's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ortin Global Total Liabilities Chart

Ortin Global Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 97.48 103.32 38.40 18.03 34.10

Ortin Global Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.03 0.00 25.26 0.00 34.10
BOM:539287
43GF Score
Ortin Global Ltd BOM:539287
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ortin Global Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Ortin Global's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=24.051+(10.05+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=34.10

Total Liabilities=Total Assets (A: Mar. 2026 )-Total Equity (A: Mar. 2026 )
=46.472-12.371
=34.10

Ortin Global's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=24.051+(10.05+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=34.10

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=46.472-12.371
=34.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ₹34.10 Mil mean?
Ortin Global (BOM:539287) has a Total Liabilities of ₹34.10 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Ortin Global and its competitors.
Is Ortin Global's Total Liabilities too high?
Ortin Global's current Total Liabilities is ₹34.10 Mil. Overall, Ortin Global has a GF Score™ of 43/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ortin Global's Total Liabilities compare to ZTS?
Ortin Global's Total Liabilities of ₹34.10 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Ortin Global and its competitors. Ortin Global's current Total Liabilities is ₹34.10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ortin Global stock overvalued right now?
Based on GuruFocus' analysis, Ortin Global (BOM:539287) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹2.50, compared to a current price of ₹15.00 — trading 500% above its estimated fair value. The current Total Liabilities is ₹34.10 Mil. Ortin Global's overall GF Score™ is 43/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Ortin Global (BOM:539287), the current Total Liabilities is ₹34.10 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ortin Global (BOM:539287) Overvalued in 2026?

Based on GuruFocus' analysis, Ortin Global stock appears to be overvalued. The current stock price of ₹15.00 is trading 500% above its estimated GF Value™ of ₹2.50. GuruFocus considers Ortin Global to be Significantly Overvalued.

Key valuation signals for BOM:539287:

  • Total Liabilities: ₹34.10 Mil
  • GF Value™: ₹2.50 vs. price of ₹15.00 (500% above fair value)
  • GF Score™: 43/100 with 6 warning signs

No single metric tells the full story. See the BOM:539287 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ortin Global Business Description

Other Exchanges ORTINGLOBE:India
Address G Block, Plot No. C-66, 9th Floor, 915, One BKC, Bandra Kurla Complex, Bandra East, Mumbai, MH, IND, 400051
Ortin Global Ltd is an Indian company engaged in the manufacturing and trading of Pharmaceuticals, Drugs, and Intermediates. Its formulations include anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helminthics, analgesics and antipyretics, antibiotics, antifungal, cephalosporins, and others. Some of its API intermediates include Ciprofloxacin, Tramadol, Efavarenz, Lamivudine, Zidovudine, Nevirapine, Lopinavir, Fluconazole, Triclabendazole, Omeprazole, and others. Additionally, the company is also involved in the real estate business.
43GF Score

Get the complete analysis for BOM:539287

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹15.00
Price
₹2.50
GF Value